REVOLUTION MEDICINES INC (RVMD) Stock Analyst Earnings Estimates
NASDAQ:RVMD - Nasdaq - US76155X1000 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 29.39M -31.62% | 35.38M 20.38% | 11.58M -67.27% | 306K -100.00% | 9.69M | 31.669M 226.82% | 175.29M 453.51% | 674.66M 284.88% | 1.538B 127.97% | 2.733B 77.70% | 2.792B 2.16% | 3.289B 17.80% | |
| EBITDA YoY % growth | -183.86M -71.80% | -253.24M -37.74% | -481.075M -89.97% | -673.512M -41.74% | -997.961M -46.35% | -1.082B -8.43% | -1.103B -1.96% | -558.042M 49.42% | -206.417M 63.01% | 1.167B 665.36% | 2.877B 146.53% | 4.344B 50.99% | |
| EBIT YoY % growth | -188.01M -69.84% | -258.28M -37.38% | -487.185M -88.63% | -680.641M -41.53% | -997.089M -44.61% | -1.062B -6.54% | -970.057M 8.68% | -300.374M 69.04% | 453.49M 250.98% | 1.282B 182.70% | 1.905B 48.60% | 2.354B 23.57% | |
| Operating Margin | -639.71% | -730.02% | -4,207.12% | -222,431.83% | -10,289.87% | -3,354.28% | -553.40% | -44.52% | 29.49% | 46.91% | 68.23% | 71.57% | |
| EPS YoY % growth | -2.56 -19.63% | -3.10 -21.09% | -3.77 -21.71% | -3.54 5.38% | -4.66 -30.57% | -5.06 -8.54% | -4.82 4.79% | -1.52 68.40% | 3.07 301.68% | 8.42 174.09% | 15.37 82.67% | 22.48 46.25% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -1.16 -43.38% | -1.10 -16.70% | -1.25 -11.42% | -1.30 -15.24% | -1.00 13.76% | -1.01 8.23% | -1.03 17.77% |
| Revenue Q2Q % growth | 2.867M | 2.867M | 2.867M | N/A | 1.042M -63.66% | 5.84M 103.70% | |
| EBITDA Q2Q % growth | -248.916M -62.77% | -253.496M -49.04% | -256.775M -23.05% | -216.24M 6.90% | -217.26M 12.72% | -218.28M 13.89% | -219.3M 14.59% |
| EBIT Q2Q % growth | -239.618M -52.97% | -249.618M -42.06% | -257.371M -18.98% | -263.976M -19.82% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2025 Q2Q % growth | -1.13 -61.43% | -1.11 | -0.02 | -1.54% |
| Q4 2024 Q2Q % growth | -1.12 1.75% | -1.01 | -0.11 | -11.25% |
| Q3 2024 Q2Q % growth | -0.94 5.34% | -0.91 | -0.03 | -3.17% |
| Q2 2024 Q2Q % growth | -0.81 11.96% | -0.79 | -0.02 | -2.48% |
| Q1 2024 Q2Q % growth | -0.70 2.78% | -0.76 | 0.06 | 8.02% |
| Q4 2023 Q2Q % growth | -1.14 -80.95% | -0.90 | -0.24 | -26.70% |
| Q3 2023 Q2Q % growth | -0.99 -14.14% | -1.03 | 0.03 | 3.23% |
| Q2 2023 Q2Q % growth | -0.92 -12.20% | -0.84 | -0.08 | -9.49% |
| Q1 2023 Q2Q % growth | -0.72 7.69% | -0.83 | 0.11 | 13.23% |
| Q4 2022 Q2Q % growth | -0.63 11.27% | -0.84 | 0.21 | 24.84% |
| Q3 2022 Q2Q % growth | -0.87 -20.83% | -0.86 | -0.01 | -1.27% |
| Q2 2022 Q2Q % growth | -0.82 -36.67% | -0.87 | 0.05 | 5.39% |
| Q1 2022 Q2Q % growth | -0.78 -47.17% | -0.79 | 0.01 | 1.31% |
| Q4 2021 Q2Q % growth | -0.71 -36.54% | -0.65 | -0.06 | -9.01% |
| Q3 2021 Q2Q % growth | -0.72 -71.43% | -0.64 | -0.08 | -12.86% |
| Q2 2021 Q2Q % growth | -0.60 -30.43% | -0.57 | -0.03 | -5.04% |
| Q1 2021 Q2Q % growth | -0.53 28.38% | -0.53 | 0.00 | 0.84% |
| Q4 2020 Q2Q % growth | -0.52 92.02% | -0.39 | -0.13 | -32.76% |
| Q3 2020 Q2Q % growth | -0.42 | -0.40 | -0.02 | -5.04% |
| Q2 2020 Q2Q % growth | -0.46 | -0.37 | -0.09 | -24.58% |
| Q1 2020 Q2Q % growth | -0.74 | -0.34 | -0.40 | -118.19% |
| Q4 2019 Q2Q % growth | -6.52 | -0.42 | -6.10 | -1,459.06% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -100.00% | 353.073K | -353.073K | -100.00% |
| Q3 2024 Q2Q % growth | 327.859K | -327.859K | -100.00% | |
| Q2 2024 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q1 2024 Q2Q % growth | -100.00% | 1.404M | -1.404M | -100.00% |
| Q4 2023 Q2Q % growth | 742K -95.16% | 1.113M | -371K | -33.33% |
| Q3 2023 Q2Q % growth | -100.00% | 765K | -765K | -100.00% |
| Q2 2023 Q2Q % growth | 3.824M -58.07% | 1.594M | 2.23M | 139.90% |
| Q1 2023 Q2Q % growth | 7.014M -7.47% | 2.996M | 4.018M | 134.11% |
| Q4 2022 Q2Q % growth | 15.33M 62.05% | 7.908M | 7.422M | 93.85% |
| Q3 2022 Q2Q % growth | 3.36M 205.45% | 6.406M | -3.046M | -47.55% |
| Q2 2022 Q2Q % growth | 9.12M 4.83% | 7.159M | 1.961M | 27.39% |
| Q1 2022 Q2Q % growth | 7.58M -25.17% | 8.67M | -1.09M | -12.57% |
| Q4 2021 Q2Q % growth | 9.46M 8.11% | 9.096M | 364K | 4.00% |
| Q3 2021 Q2Q % growth | 1.1M -91.31% | 8.874M | -7.774M | -87.60% |
| Q2 2021 Q2Q % growth | 8.7M -13.26% | 9.571M | -871K | -9.10% |
| Q1 2021 Q2Q % growth | 10.13M -12.29% | 9.649M | 481K | 4.98% |
| Q4 2020 Q2Q % growth | 8.75M -27.63% | 17.116M | -8.366M | -48.88% |
| Q3 2020 Q2Q % growth | 12.66M 1.20% | 14.525M | -1.865M | -12.84% |
| Q2 2020 Q2Q % growth | 10.03M -18.32% | 13.627M | -3.597M | -26.40% |
| Q1 2020 Q2Q % growth | 11.55M -12.30% | 13.643M | -2.093M | -15.34% |
| Q4 2019 Q2Q % growth | 12.09M | 13.107M | -1.017M | -7.76% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -1.44% | 3.1% | -0.16% |
| Revenue | N/A | N/A | 603.7% | 480.59% |